Health Condition 1: A239- Brucellosis, unspecified Health Condition 2: A90- Dengue fever [classical dengue] Health Condition 3: B159- Hepatitis A without hepatic coma Health Condition 4: A279- Leptospirosis, unspecified Health Condition 5: B978- Other viral agents as the cause ofdiseases classified elsewhere Health Condition 6: A010- Typhoid fever Health Condition 7: A759- Typhus fever, unspecified
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
SARATH A
Eligibility
Inclusion criteria
Inclusion criteria: Acute febrile illness (fever >38.3?C for more than 48 h duration and onset
Exclusion criteria
Exclusion criteria: 1.Patients already treated in an outside ICU for more than 72 hrs. 2.Patient with immunodeficiency state (congenital oracquired); on immune-suppressants therapy (oral corticosteroids, combination chemotherapy); and with autoimmune disorders, malignancies or organ transplants. 3.Patients with pre-existing chronic conditions- chronic liver disease, chronic kidney disease, malignancy. 4. Anemia of chronic disease due to any cause
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome To assess association between serum ferritin levels in tropical fever patients measured within 72 hrs of ICU admission to ICU mortality & ICU length of stay . Timepoint: Until icu stay or death | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes 1.To assess the incidence of secondary HLH in tropical infections admitted to ICU . 2. To assess the association between secondary HLH & ICU mortality & ICU length of stay. 3. To assess the mortality difference among patients treated with & without steroids based on serum ferritin levels alone. Timepoint: until icu stay | — |
Countries
India
Contacts
Public ContactSarath A
St Johns medical college
Outcome results
None listed